VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AEMDAethlon Medical, Inc.
$1.89$1M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAEMDEarnings History

AEMD logoAethlon Medical, Inc. (AEMD) Earnings History

Net Loss

30 years of earnings data (1997–2026) · Currently unprofitable on a TTM basis

TTM Net Income
-$7M
● Net Loss
TTM EPS (Diluted)
$-4.55
Per share, diluted
YoY EPS Growth
+87.6%
Excellent
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity-142.9%
Return on Assets-104.5%
Record Annual Net Income-$1,534FY1997
Record Quarterly EPS$204.40Q4 2011
Consecutive Profitable Years0years
Q4 2026
Net Income-$2M
EPS (Diluted)$-1.20
YoY Growth+87.6%Excellent
QoQ Growth+6.6%Solid

Loading earnings history...

Aethlon Medical, Inc. (AEMD) Earnings Overview

As of June 22, 2026, Aethlon Medical, Inc. (AEMD) reported trailing twelve-month net income of -$7M, reflecting +87.6% year-over-year growth. The company earned $-4.55 per diluted share over the past four quarters.

Looking at the long-term picture, AEMD's historical earnings data spans multiple years. The company achieved its highest annual net income of -$1,534 in fiscal 1997.

Aethlon Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including XTLB (-$1M net income, -227.7% margin), EKSO (-$16M net income, -91.4% margin), PRTH ($57M net income, 5.8% margin), AEMD has comparable earnings metrics. Compare AEMD vs XTLB →

AEMD Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
AEMD logoAEMDCurrent
-$7M$-4.55--142.9%+87.6%—
XTLB logoXTLB
-$1M$-9.33-227.7%-26.8%-
EKSO logoEKSO
-$16M$-4.40-91.4%-107.6%-776.8%
PRTH logoPRTH
$57M$0.685.8%-+319.4%
TELA logoTELA
-$40M$-0.70-48.4%-223.4%+37.6%
BAX logoBAX
-$1.1B$-2.13-8.5%-14.6%-37.8%
Best in group
Lowest in group

AEMD Historical Earnings Data (1997–2026)

30 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2026-$7M+46.6%-$7M$-10.61--
2025-$13M-9.7%-$9M$-85.80--
2024-$12M-1.5%-$13M$-48.60--
2023-$12M-15.5%-$12M$-58.60-2094.9%-2072.0%
2022-$10M-32.1%-$10M$-70.60-3540.9%-3542.5%
2021-$8M-23.7%-$8M$-65.20-1196.6%-1197.3%
2020-$6M-2.9%-$6M$-186.70-980.3%-912.0%
2019-$6M-9.1%-$6M$-512.70-2697.9%-2612.5%
2018-$6M+21.9%-$5M$-691.70-3796.2%-3228.7%
2017-$7M-49.3%-$6M$-1410.00-1855.8%-1555.3%
2016-$5M+28.3%-$4M$-988.50-549.5%-494.6%
2015-$7M+49.1%-$4M$-1822.50-891.5%-523.7%
2014-$13M-173.0%-$3M$-5160.00-822.5%-188.2%
2013-$5M+39.7%-$4M$-2458.80-397.7%-290.7%
2012-$8M-42.0%-$3M$-0.80-596.4%-229.0%
2011-$6M-24.9%-$5M$-615.40--
2010-$5M+24.8%-$3M$-605.80--
2009-$6M-47.0%-$3M$-1062.50--
2008-$4M+31.3%-$3M$-902.80--
2007-$6M-106.3%-$2M$-1677.40--
2006-$3M-39.2%-$2M$-1120.20--
2005-$2M-38.1%-$2M$-1120.40--
2004-$2M+38.3%$-996,000$-1392.40--
2003-$2M+38.4%-$2M$-3324.00--
2002-$4M+9.7%-$2M$-7806.00--
2001-$4M-240.5%-$2M$-91575.00--
2000-$1M-268.3%$-890,000$-3730.60--
1999$-352,679+28.3%$-340,578$-1755.50--
1998$-491,872-31964.7%$-456,651$-14216.00-2455.1%-2279.3%
1997$-1,534-$-1,534$-0.00--

Download Data

Export AEMD earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

29+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AEMD — Frequently Asked Questions

Quick answers to the most common questions about buying AEMD stock.

What is AEMD earnings per share (EPS)?

AEMD trailing twelve-month (TTM) diluted EPS is $-4.55, reflecting +87.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1997 to 2026 is available in the table on this page.

What is Aethlon Medical, Inc.'s net income?

Aethlon Medical, Inc. (AEMD) trailing twelve-month net income is $-7M as of 2026. Earnings grew +87.6% year-over-year.

Is AEMD profitable?

AEMD is not currently profitable on a TTM basis, reporting a net loss of $-7M. Net margin is N/A. Investors should monitor for a return to profitability.

What is AEMD's earnings growth rate?

AEMD compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1997 to 2026.

What are AEMD's profit margins?

Aethlon Medical, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -142.9%.

Is AEMD growing earnings?

Yes, AEMD earnings are accelerating — EPS growth of +87.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-7M. Earnings momentum is strengthening.

What was AEMD's best earnings year?

Aethlon Medical, Inc.'s highest annual net income on record is $-1534.00, achieved in fiscal year 1997. Earnings history on this page spans 1997 to 2026 and includes all annual and quarterly figures.

What were AEMD's earnings last quarter?

AEMD's most recent reported quarter was Q4 2026. Net income was $-2M with diluted EPS of $-1.20. For a full breakdown of all quarters, see the quarterly earnings table on this page.

AEMD Earnings Over Time (1997–2026)

Net income & EPS — annual and quarterly view